Suppliers / Uspharma

Uspharma

United States Updated 9 July 2026

Uspharma is a finished-dose manufacturer based in United States. It appears in 29 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam) and US FDA. Its most recent recorded inspection, by US FDA, closed on 16 February 2023 as NAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
29
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 16 February 2023 NAI US FDA
  • 23 June 2022 VAI US FDA
  • 3 February 2015 NAI US FDA
  • 2 April 2012 NAI US FDA
  • 11 May 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Miami Lake, United States 1010370

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 28 None
US FDA 1 None

Questions about Uspharma

Does Uspharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Uspharma. It does have 29 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Uspharma FDA-registered?
One site operated by Uspharma carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Uspharma's last inspection go?
The most recent inspection on record closed on 16 February 2023 as NAI (No Action Indicated: nothing objectionable was found). 5 inspections are on file.
Where does Uspharma manufacture?
1 registered site is on record, in United States (Miami Lake). Every site is listed on this page with the register it came from.
Where does Uspharma file?
Filings are on record with DAV (Vietnam) and US FDA, 29 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Uspharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 16 February 2023.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability